Studies that have reported that Interferon (IFN) therapy, even after curative treatment for HCV-related HCC, could prevent HCC recurrence and improve survival,[39, 40] despite the mechanisms by which IFN suppresses HCC recurrence, including possible direct anti-tumor and anti-inflammatory effects, remain uncertain. Here, IFNA1 is linked to hepatocellular carcinoma.